Data Package for study.
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00001500.0
下载链接
链接失效反馈官方服务：
资源简介：
This is a randomized, double-blind, multicenter, phase 3 study evaluating orteronel plus prednisone compared with placebo plus prednisone in men with metastatic, castration-resistant prostate cancer (mCRPC) that has progressed following Docetaxel-based therapy
提供机构：
Vivli
创建时间：
2024-07-24
